Document Detail


Primary malignant bone neoplasm: a case report of dedifferentiated chondrosarcoma in the rib and review of the literature.
MedLine Citation:
PMID:  20979697     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dedifferentiated chondrosarcoma (DDCS) is a rare but highly malignant primary bone neoplasm, which is resistant to radiotherapy and chemotherapy. There remains uncertainly as to the best treatment of this disease and how to improve its prognosis. In this paper we reported a case of DDCS and reviewed the related literatures in order to provide references to throw a light on the histogenesis, diagnosis and therapy of this disease.
Authors:
Jin-Rong Lin; Wei-Min Zhang; Zhuo-Cai Wang
Related Documents :
7560457 - Erythema gyratum repens unassociated with underlying malignancy.
17309187 - Primitive neurectodermal tumors: a case of extraosseous ewing's sarcoma of the small in...
7066867 - The association between kaposi's sarcoma and dysgammaglobulinemia.
3365087 - Kaposi's sarcoma in an elderly man with wegener's granulomatosis treated with cyclophos...
11127147 - Pharyngocutaneous fistula and total laryngectomy: possible predisposing factors, with e...
24267357 - Evaluation and management of hypersensitivity to proton pump inhibitors.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Chinese journal of cancer     Volume:  29     ISSN:  1000-467X     ISO Abbreviation:  Chin J Cancer     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-28     Completed Date:  2012-02-16     Revised Date:  2013-02-12    
Medline Journal Info:
Nlm Unique ID:  101498232     Medline TA:  Chin J Cancer     Country:  China    
Other Details:
Languages:  eng     Pagination:  964-8     Citation Subset:  IM    
Affiliation:
Oncology Department, Guangzhou General Hospital of PLA, Guangzhou, Guangdong 510010, PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Neoplasms / drug therapy,  pathology,  radionuclide imaging*
Chondrosarcoma / drug therapy,  pathology,  radionuclide imaging*
Cisplatin / administration & dosage
Doxorubicin / administration & dosage,  analogs & derivatives
Follow-Up Studies
Hemangioendothelioma / drug therapy,  radionuclide imaging,  secondary*
Humans
Immunohistochemistry
Lung Neoplasms / drug therapy,  radionuclide imaging,  secondary*
Male
Methotrexate / administration & dosage
Positron-Emission Tomography and Computed Tomography
Ribs*
Chemical
Reg. No./Substance:
15663-27-1/Cisplatin; 23214-92-8/Doxorubicin; 59-05-2/Methotrexate; 72496-41-4/pirarubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer.
Next Document:  Anti-cancer effects of Phyllanthus urinaria and relevant mechanisms.